Jaguar Health Inc
NASDAQ:JAGX

Watchlist Manager
Jaguar Health Inc Logo
Jaguar Health Inc
NASDAQ:JAGX
Watchlist
Price: 2.15 USD
Market Cap: 3.5m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

JAGX Price Targets Summary
Jaguar Health Inc

There are no price targets for JAGX.
JAGX Lowest Forecast
Wall Street Target
Not Available
JAGX Average Forecast
Wall Street Target
Not Available
JAGX Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Jaguar Health Inc Competitors:
Price Targets
J
600380
Joincare Pharmaceutical Group Industry Co Ltd
10% Upside
NEU
Neuren Pharmaceuticals Ltd
50% Upside
GRANULES
Granules India Ltd
37% Upside
PBH
Prestige Consumer Healthcare Inc
26% Upside
J
600380
Joincare Pharmaceutical Group Industry Co Ltd
10% Upside
NEU
Neuren Pharmaceuticals Ltd
50% Upside
GRANULES
Granules India Ltd
37% Upside
PBH
Prestige Consumer Healthcare Inc
26% Upside
MARKSANS
Marksans Pharma Ltd
46% Upside
2070
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC
12% Upside
XERS
Xeris Biopharma Holdings Inc
21% Upside
P
300363
Porton Pharma Solutions Ltd
7% Downside

Revenue
Forecast

Revenue Estimate
Jaguar Health Inc

The compound annual growth rate of Jaguar Health Inc's revenue for the next 2 years is 26%.

N/A
Past Growth
26%
Estimated Growth
Estimates Accuracy
-8%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Jaguar Health Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Jaguar Health Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss
What are analyst estimates?

See Also

Summary
JAGX intrinsic value, competitors valuation, and company profile.
DCF Valuation
JAGX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
JAGX stock valuation using valuation multiples.
Wall Street Estimates
JAGX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
JAGX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is JAGX's stock price target?
Not Available

JAGX doesn't have any price targets made by Wall Street professionals.

What is Jaguar Health Inc's Revenue forecast?
Projected CAGR
26%

The compound annual growth rate of Jaguar Health Inc's revenue for the next 2 years is 26%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 272,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.